Sign in
4

Changes in Ownership

Ensysce Biosciences, Inc. Filed Acc 0001192482-21-000618

Chief Executive Officer acquired 284,851 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kirkpatrick Lynn Chief Executive Officer 2021-06-30 Grant or award +284,851 284,851 D
Derivatives
Kirkpatrick Lynn Chief Executive Officer 2021-06-30 Grant or award · Stock Option +99,950 99,950 D
Kirkpatrick Lynn Chief Executive Officer 2021-06-30 Grant or award · Stock Option +9,994 9,994 D
Kirkpatrick Lynn Chief Executive Officer 2021-06-30 Grant or award · Stock Option +263,400 263,400 D
Kirkpatrick Lynn Chief Executive Officer 2021-06-30 Grant or award · Stock Option +460,950 460,950 D
Kirkpatrick Lynn Chief Executive Officer 2021-06-30 Grant or award · Stock Option +817,560 817,560 D
Kirkpatrick Lynn Chief Executive Officer 2021-06-30 Grant or award · Stock Option +658,500 658,500 D
Kirkpatrick Lynn Chief Executive Officer 2021-06-30 Grant or award · Stock Option +6,585 6,585 D
Loading xslF345X03/edgar.xml…